Skip to main content

Table 3 Overall and subgroup meta-analyses of association between rs1801516 polymorphism and cancer susceptibility under different models

From: Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls

Group

AA vs GG + GA

AA+GA vs GG

AA vs GG

GA vs GG

GG + AA vs GA

OR (95% CI)

I2 (%)

P h

OR (95% CI)

I2 (%)

P h

OR (95% CI)

I2 (%)

P h

OR (95% CI)

I2 (%)

P h

OR (95% CI)

I2 (%)

P h

Overall

0.91 (0.78, 1.07)

< 0.1

0.616

1.00 (0.90, 1.11)

60.8

< 0.001

0.89 (0.75, 1.06)

5.8

0.378

1.01 (0.91, 1.13)

77.14

< 0.001

1.00 (0.88, 1.10)

74.4

< 0.001

Region-specified population

 European

0.79 (0.65, 0.96)

< 0.1

0.848

0.94 (0.82, 1.07)

65.6

< 0.001

0.79 (0.65, 0.96)

< 0.1

0.677

0.95 (0.84, 1.08)

61.9

< 0.001

1.04 (0.92, 1.18)

60.0

< 0.001

 North American

1.09 (0.82, 1.45)

< 0.1

0.566

1.02 (0.90, 1.15)

43.6

0.077

1.32 (0.85, 2.06)

< 0.1

0.408

1.03 (0.80, 1.32)

52.3

0.050

0.97 (0.76, 1.25)

52.5

0.049

 South American

1.07 (0.1, 11.88)

–

–

2.15 (1.37, 3.38)

16.6

0.274

1.24 (0.11, 13.84)

–

–

2.19 (1.38, 3.47)

33.2

0.221

0.46 (0.29, 0.72)

32.7

0.223

 Asian

7.45 (1.31, 42.46)

< 0.1

0.956

1.11 (0.79, 1.58)

< 0.1

0.719

7.40 (1.30, 42.19)

< 0.1

0.949

1.00 (0.70, 1.43)

< 0.1

0.592

1.02 (0.71, 1.46)

< 0.1

0.584

 Oceanian

1.83 (0.55, 6.05)

–

–

2.20 (0.87, 5.58)

–

–

–

–

–

2.20 (0.87, 5.58)

–

–

0.46 (0.18, 1.16)

–

–

Cancer type

 Breast cancer

0.84 (0.68, 1.04)

< 0.1

0.777

1.09 (0.86, 1.38)

78.0

< 0.001

0.76 (0.59, 0.98)

< 0.1

0.632

1.11 (0.87, 1.41)

76.4

< 0.001

0.90 (0.71, 1.13)

75.3

< 0.001

 Thyroid cancer

0.73 (0.48, 1.11)

< 0.1

0.886

0.87 (0.71, 1.07)

52.3

0.033

0.71 (0.47, 1.08)

< 0.1

0.830

0.89 (0.67, 1.18)

60.6

0.018

1.11 (0.84, 1.47)

59.1

0.023

 Cervical cancer

2.29 (0.89, 5.91)

< 0.1

0.379

0.86 (0.63, 1.18)

< 0.1

0.443

2.13 (0.83, 5.48)

5.8

0.346

0.79 (0.57, 1.09)

< 0.1

0.489

1.29 (0.93, 1.79)

< 0.1

0.494

 Colorectal cancer

0.44 (0.12, 1.59)

< 0.1

0.953

1.13 (0.83, 1.54)

< 0.1

0.874

0.47 (0.13, 1.69)

< 0.1

0.966

1.20 (0.87, 1.64)

< 0.1

0.899

0.82 (0.60, 1.12)

< 0.1

0.903

 Lung cancer

1.22 (0.35, 4.20)

55.4

0.134

1.41 (0.97, 2.05)

–

–

2.71 (0.69, 10.61)

–

–

1.35 (0.92, 1.98)

–

–

0.76 (0.52, 1.12)

–

–

Source of controls

 PBC

0.83 (0.65, 1.07)

< 0.1

0.858

0.99 (0.81, 1.21)

70.8

< 0.001

0.75 (0.55, 1.03)

< 0.1

0.771

1.03 (0.83, 1.28)

70.8

< 0.001

0.96 (0.78, 1.19)

69.9

< 0.001

 HBC

1.04 (0.80, 1.36)

17.2

0.285

1.02 (0.86, 1.20)

62.5

0.002

1.06 (0.80, 1.42)

36.2

0.140

1.03 (0.86, 1.23)

62.2

0.003

0.98 (0.82, 1.17)

60.8

0.004

 NR

0.88 (0.64, 1.20)

24.0

0.254

0.93 (0.82, 1.06)

< 0.1

0.827

0.86 (0.63, 1.18)

26.2

0.238

0.93 (0.82, 1.07)

< 0.1

0.928

1.06 (0.93, 1.20)

< 0.1

0.944

Matched controls

 Yes

0.95 (0.79, 1.14)

< 0.1

0.514

0.97 (0.84, 1.12)

64.8

< 0.001

0.93 (0.75, 1.15)

18

0.238

0.99 (0.86, 1.14)

62.4

< 0.001

1.01 (0.88, 1.16)

60.5

< 0.001

 No

0.82 (0.59, 1.12)

< 0.1

0.567

1.02 (0.86, 1.21)

54.9

0.011

0.81 (0.59, 1.11)

< 0.1

0.565

1.06 (0.87, 1.29)

58.2

0.008

0.94 (0.77, 1.14)

57.9

0.008

Family history

 Yes

0.70 (0.48, 1.00)

< 0.1

0.574

1.20 (0.85, 1.71)

73.1

0.001

0.68 (0.47, 0.98)

< 0.1

0.519

1.25 (0.88, 1.77)

71.2

0.002

0.80 (0.57, 1.12)

69.9

0.003

 No

0.98 (0.82, 1.16)

< 0.1

0.634

0.97 (0.87, 1.09)

57.9

< 0.001

0.97 (0.79, 1.18)

5.2

0.39

0.98 (0.87, 1.11)

57.5

< 0.001

1.02 (0.90, 1.14)

56

< 0.001

Sample size

  < 1000

0.95 (0.75, 1.20)

< 0.1

0.601

0.99 (0.85, 1.15)

56.8

< 0.001

0.89 (0.67, 1.20)

4.7

0.399

1.01 (0.85, 1.19)

56.4

< 0.001

0.99 (0.84, 1.17)

54.9

0.001

  > 1000

0.89 (0.72, 1.10)

2.0

0.420

1.01 (0.87, 1.17)

71.6

< 0.001

0.89 (0.71, 1.11)

18.1

0.282

1.02 (0.88, 1.18)

69.9

0.001

0.98 (0.84, 1.13)

68.7

0.001

HWE in controls

 Yes

0.87 (0.73, 1.05)

< 0.1

0.74

0.99 (0.89, 1.10)

57.5

< 0.001

0.87 (0.72, 1.05)

< 0.1

0.58

1.00 (0.89, 1.12)

56.7

< 0.001

0.99 (0.89, 1.11)

54.9

< 0.001

 No

1.09 (0.64, 1.84)

56.0

0.078

1.06 (0.70, 1.61)

76.3

0.005

0.95 (0.36, 2.50)

58.3

0.066

1.08 (0.72, 1.63)

74.4

0.008

0.92 (0.62, 1.38)

73.5

0.010

 NR

1.03 (0.69, 1.52)

< 0.1

0.631

29.24 (1.71, 501.48)

–

–

–

–

–

29.24 (1.71, 501.48)

–

–

0.03 (0.00, 0.59)

–

–

  1. HBC, hospital-based case–controls; PBC, population-based case–controls; NR, not report
  2. Ph, P value of Q test for heterogeneity
  3. Significant ORs (95% CIs) were in bold